Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 3
2012 1
2013 7
2014 9
2015 8
2016 14
2017 19
2018 11
2019 12
2020 20
2021 16
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

115 results
Results by year
Filters applied: . Clear all
Page 1
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.
Tolaney SM, Tayob N, Dang C, Yardley DA, Isakoff SJ, Valero V, Faggen M, Mulvey T, Bose R, Hu J, Weckstein D, Wolff AC, Reeder-Hayes K, Rugo HS, Ramaswamy B, Zuckerman D, Hart L, Gadi VK, Constantine M, Cheng K, Briccetti F, Schneider B, Garrett AM, Marcom K, Albain K, DeFusco P, Tung N, Ardman B, Nanda R, Jankowitz RC, Rimawi M, Abramson V, Pohlmann PR, Van Poznak C, Forero-Torres A, Liu M, Ruddy K, Zheng Y, Rosenberg SM, Gelber RD, Trippa L, Barry W, DeMeo M, Burstein H, Partridge A, Winer EP, Krop I. Tolaney SM, et al. Among authors: reeder hayes k. J Clin Oncol. 2021 Jul 20;39(21):2375-2385. doi: 10.1200/JCO.20.03398. Epub 2021 Jun 2. J Clin Oncol. 2021. PMID: 34077270 Clinical Trial.
Haunted.
Reeder-Hayes KE. Reeder-Hayes KE. J Clin Oncol. 2017 Jan;35(1):113-114. doi: 10.1200/JCO.2016.70.7273. Epub 2016 Nov 14. J Clin Oncol. 2017. PMID: 28034072 No abstract available.
Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.
Moy B, Rumble RB, Come SE, Davidson NE, Di Leo A, Gralow JR, Hortobagyi GN, Yee D, Smith IE, Chavez-MacGregor M, Nanda R, McArthur HL, Spring L, Reeder-Hayes KE, Ruddy KJ, Unger PS, Vinayak S, Irvin WJ Jr, Armaghani A, Danso MA, Dickson N, Turner SS, Perkins CL, Carey LA. Moy B, et al. Among authors: reeder hayes ke. J Clin Oncol. 2021 Dec 10;39(35):3938-3958. doi: 10.1200/JCO.21.01374. Epub 2021 Jul 29. J Clin Oncol. 2021. PMID: 34324366
The Gambler.
Reeder-Hayes KE. Reeder-Hayes KE. J Clin Oncol. 2019 Dec 10;37(35):3460-3461. doi: 10.1200/JCO.19.01375. Epub 2019 Jul 30. J Clin Oncol. 2019. PMID: 31361536 No abstract available.
Response to Strassels and Durham.
Check DK, Winn AN, Fergestrom N, Reeder-Hayes KE, Neuner JM, Roberts AW. Check DK, et al. Among authors: reeder hayes ke. J Natl Cancer Inst. 2020 Dec 14;112(12):1280. doi: 10.1093/jnci/djaa146. J Natl Cancer Inst. 2020. PMID: 32956444 Free PMC article. No abstract available.
Does It Ever Go Away?
Reeder-Hayes KE. Reeder-Hayes KE. JAMA Pediatr. 2019 Oct 1;173(10):912-913. doi: 10.1001/jamapediatrics.2019.2797. JAMA Pediatr. 2019. PMID: 31424525 No abstract available.
Health disparities across the breast cancer continuum.
Reeder-Hayes KE, Wheeler SB, Mayer DK. Reeder-Hayes KE, et al. Semin Oncol Nurs. 2015 May;31(2):170-7. doi: 10.1016/j.soncn.2015.02.005. Epub 2015 Feb 16. Semin Oncol Nurs. 2015. PMID: 25951746 Free PMC article. Review.
Providers' mediating role for medication adherence among cancer survivors.
Trogdon JG, Amin K, Gupta P, Urick BY, Reeder-Hayes KE, Farley JF, Wheeler SB, Spees L, Lund JL. Trogdon JG, et al. Among authors: reeder hayes ke. PLoS One. 2021 Nov 29;16(11):e0260358. doi: 10.1371/journal.pone.0260358. eCollection 2021. PLoS One. 2021. PMID: 34843550 Free PMC article.
115 results